{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:26:38Z","timestamp":1793071598491,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/04877-2"],"award-info":[{"award-number":["2016\/04877-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/18538-0"],"award-info":[{"award-number":["2018\/18538-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/23044-1"],"award-info":[{"award-number":["2016\/23044-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI127381-02"],"award-info":[{"award-number":["AI127381-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jcyt.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T09:07:55Z","timestamp":1607332075000},"page":"119-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Thiago Aparecido","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Bandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Laskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pappanaicken R.","family":"Kumaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcyt.2020.11.002_bib0001","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13693786.2011.607854","article-title":"Cryptococcus gattii: where do we go from here?","volume":"50","author":"Harris","year":"2012","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ccm.2017.04.007","article-title":"Cryptococcal Lung Infections","volume":"38","author":"Skolnik","year":"2017","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.jcyt.2020.11.002_bib0003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.jcyt.2020.11.002_bib0004","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/IAI.00080-06","article-title":"Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection","volume":"74","author":"Lindell","year":"2006","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0005","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.01477-13","article-title":"Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production","volume":"82","author":"Murdock","year":"2014","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0006","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/IAI.00094-07","article-title":"The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response","volume":"75","author":"Zaragoza","year":"2007","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.17.6.2879","article-title":"IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice","volume":"17","author":"Hoag","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0008","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/IAI.73.3.1788-1796.2005","article-title":"The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans","volume":"73","author":"Chen","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0009","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pathol-012513-104653","article-title":"The intracellular life of Cryptococcus neoformans","volume":"9","author":"Coelho","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"10.1016\/j.jcyt.2020.11.002_bib0010","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/IAI.01773-14","article-title":"Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts","volume":"82","author":"Angkasekwinai","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-immunol-020711-074958","article-title":"Adaptive immunity to fungi","volume":"30","author":"Wuthrich","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/249482","article-title":"Direct microbicidal activity of cytotoxic T-lymphocytes","volume":"2010","author":"Oykhman","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/iai.62.1.194-202.1994","article-title":"Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans","volume":"62","author":"Levitz","year":"1994","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.jcyt.2020.11.002_bib0014","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/IAI.67.2.936-941.1999","article-title":"The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes","volume":"67","author":"Mody","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41467-018-03014-4","article-title":"Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0016","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.1203435","article-title":"Scavenger receptor A modulates the immune response to pulmonary Cryptococcus neoformans infection","volume":"191","author":"Qiu","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3389\/fimmu.2017.01939","article-title":"Methods of Controlling Invasive Fungal Infections Using CD8(+) T Cells","volume":"8","author":"Kumaresan","year":"2018","journal-title":"Front Immunol"},{"issue":"29","key":"10.1016\/j.jcyt.2020.11.002_bib0018","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/imr.12131","article-title":"Design and development of therapies using chimeric antigen receptor-expressing T cells","volume":"257","author":"Dotti","year":"2014","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.jcyt.2020.11.002_bib0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2015.10.003","article-title":"Chimeric antigen receptor T cell therapy: 25 years in the making","volume":"30","author":"Gill","year":"2016","journal-title":"Blood Rev"},{"issue":"22","key":"10.1016\/j.jcyt.2020.11.002_bib0022","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19- specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells","volume":"66","author":"Kowolik","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0023","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"9967","key":"10.1016\/j.jcyt.2020.11.002_bib0024","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jcyt.2020.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jcyt.2020.11.002_bib0026","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jcyt.2020.11.002_bib0027","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcyt.2020.11.002_bib0028","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/jof3030047","article-title":"Immune Recognition of Fungal Polysaccharides","volume":"3","author":"Snarr","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":"31","key":"10.1016\/j.jcyt.2020.11.002_bib0030","doi-asserted-by":"crossref","first-page":"12980","DOI":"10.1073\/pnas.0902963106","article-title":"The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation","volume":"106","author":"Ma","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0065-2164(08)01005-8","article-title":"Virulence in Cryptococcus species","volume":"67","author":"Ma","year":"2009","journal-title":"Adv Appl Microbiol"},{"issue":"5","key":"10.1016\/j.jcyt.2020.11.002_bib0032","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1128\/iai.62.5.1507-1512.1994","article-title":"Polysaccharide antigens of the capsule of Cryptococcus neoformans","volume":"62","author":"Cherniak","year":"1994","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0033","first-page":"5243","article-title":"Innate immune evasion strategies against cryptococcal meningitis caused by Cryptococcus neoformans","volume":"14","author":"Yang","year":"2017","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0034","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","article-title":"Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies","volume":"42","author":"Casadevall","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jcyt.2020.11.002_bib0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine- derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jcyt.2020.11.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007945","article-title":"Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype","volume":"15","author":"Hommel","year":"2019","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.jcyt.2020.11.002_bib0037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1753425919869436","article-title":"iNOS\/Arginase-1 expression in the pulmonary tissue over time during Cryptococcus gattii infection","volume":"26","author":"Oliveira-Brito","year":"2019","journal-title":"Innate Immun"},{"issue":"4","key":"10.1016\/j.jcyt.2020.11.002_bib0038","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","article-title":"T-cell clones can be rendered 634 specific for CD19: toward the selective augmentation of the graft-versus-B-lineage 635 leukemia effect","volume":"101","author":"Cooper","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0039","series-title":"A language and environment for statistical computing","author":"Team","year":"2018"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0040","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41467-017-02126-7","article-title":"Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects","volume":"8","author":"Almeida","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0675044c-d80f-456f-bb63-4f85fb1d0c33","article-title":"Fungal cell gigantism during mammalian infection","volume":"6","author":"Zaragoza","year":"2010","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.jcyt.2020.11.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006982","article-title":"Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators","volume":"14","author":"Hommel","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jcyt.2020.11.002_bib0043","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40425-018-0460-5","article-title":"Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance","volume":"6","author":"Boyiadzis","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.jcyt.2020.11.002_bib0044","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.ymthe.2020.06.008","article-title":"Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV","volume":"28","author":"Beck","year":"2020","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2020.11.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760170554","article-title":"The status of cryptococcosis in Latin America","volume":"113","author":"Firacative","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"10.1016\/j.jcyt.2020.11.002_bib0046","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.jcyt.2020.11.002_bib0047","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1128\/AAC.02287-12","article-title":"Azole resistance in Cryptococcus gattii from the Pacific Northwest: investigation of the role of ERG11","volume":"57","author":"Gast","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0048","doi-asserted-by":"crossref","first-page":"e00218","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jcyt.2020.11.002_bib0049","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1469-0691.2011.03741.x","article-title":"Immunotherapy of Cryptococcus infections","volume":"18","author":"Antachopoulos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0050","doi-asserted-by":"crossref","first-page":"e01817","DOI":"10.1128\/mBio.01872-17","article-title":"Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species","volume":"8","author":"Specht","year":"2017","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.jcyt.2020.11.002_bib0051","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.coi.2012.04.007","article-title":"Immunity to fungi","volume":"24","author":"LeibundGut-Landmann","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2020.11.002_bib0052","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-2164(09)01204-0","article-title":"The capsule of the fungal pathogen Cryptococcus neoformans","volume":"68","author":"Zaragoza","year":"2009","journal-title":"Adv Appl Microbiol"},{"issue":"5","key":"10.1016\/j.jcyt.2020.11.002_bib0053","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1073\/pnas.0805846106","article-title":"The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome","volume":"106","author":"Vera","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jcyt.2020.11.002_bib0054","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.smim.2013.05.005","article-title":"Carbohydrates and T cells: a sweet twosome","volume":"25","author":"Avci","year":"2013","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.jcyt.2020.11.002_bib0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/glycob\/7.6.725-d","article-title":"Carbohydrates and antigen recognition by T cells","volume":"7","author":"Carbone","year":"1997","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.jcyt.2020.11.002_bib0056","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/clinids\/18.5.789","article-title":"Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis","volume":"18","author":"Powderly","year":"1994","journal-title":"Clin Infect Dis"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920309336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920309336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:42:39Z","timestamp":1778812959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324920309336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1465324920309336"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.11.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/715045","asserted-by":"object"}]},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}